16-2319591-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001089.3(ABCA3):c.863G>A(p.Arg288Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00703 in 1,612,206 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001089.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA3 | ENST00000301732.10 | c.863G>A | p.Arg288Lys | missense_variant | Exon 8 of 33 | 1 | NM_001089.3 | ENSP00000301732.5 | ||
ABCA3 | ENST00000382381.7 | c.863G>A | p.Arg288Lys | missense_variant | Exon 8 of 32 | 1 | ENSP00000371818.3 | |||
ABCA3 | ENST00000563623.5 | n.1426G>A | non_coding_transcript_exon_variant | Exon 8 of 20 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00632 AC: 961AN: 152150Hom.: 8 Cov.: 31
GnomAD3 exomes AF: 0.00567 AC: 1415AN: 249708Hom.: 9 AF XY: 0.00549 AC XY: 741AN XY: 135006
GnomAD4 exome AF: 0.00711 AC: 10373AN: 1459942Hom.: 80 Cov.: 35 AF XY: 0.00711 AC XY: 5161AN XY: 726252
GnomAD4 genome AF: 0.00631 AC: 961AN: 152264Hom.: 8 Cov.: 31 AF XY: 0.00564 AC XY: 420AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:4
This variant is associated with the following publications: (PMID: 30413314, 24871971, 29255193, 26928390, 23166334, 27374344, 27516224, 16728712, 20981092, 22995991, 22304854, 25073622) -
- -
ABCA3: BP4, BS2 -
- -
Interstitial lung disease due to ABCA3 deficiency Uncertain:3
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
- -
This ABCA3 variant (rs117603931) reaches polymorphic frequency (greater or equal than 1%) within the European (non-Finnish) subpopulation in large population datasets (gnomAD: 1324/129014 total alleles; 1.03%; 11 homozygotes). Two submitters in ClinVar classify this variant as likely benign. This variant was previously reported as a potential disease-associated variant, however, in both cases it was located on the same chromosome (in cis) as a second, likely more deleterious ABCA3 variant. Two bioinformatic tools queried predict that this substitution would be tolerated, and the arginine residue at this position is not evolutionarily conserved across the species assessed. Multiple studies suggest that this variant may impact the function of ABCA3. Per our review and consultation with a clinical expert, this variant may contribute to an increased risk of neonatal respiratory distress in combination with other genetic and environmental factors. The clinical significance of c.863G>A is uncertain at this time. -
not specified Benign:1
p.Arg288Lys in exon 8 of ABCA3: This variant is not expected to have clinical si gnificance because it has been identified in 0.95% (642/67532) of European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs117603931). In addition, multiple mammals (>10) carry a lysine (Lys) a t this position, supporting that this change is tolerated. While this variant ha s been reported in 2 individuals with pulmonary disease (Brasch 2006, Copertino 2012), its frequency in the general population and presence of the variant amino acid in multiple mammals supports that this variant is not likely a primary cau se of disease. -
Hereditary pulmonary alveolar proteinosis Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at